Bobur Kholikov/LinkedIn
Oct 7, 2025, 13:06
Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
Bobur Kholikov, Regional Sales Manager at YHLO, shared a post on LinkedIn:
”iFlash Thrombosis Panel – D-Dimer
D-Dimer is a key biomarker of fibrin degradation, widely used to rule out or confirm thrombosis-related conditions. Elevated levels indicate active clot formation and breakdown, making it a crucial marker in emergency and routine care.
Clinical Value
- Excludes venous thromboembolism (VTE) with high negative predictive value
- Supports diagnosis of DVT, PE, and DIC
- Monitoring of anticoagulant therapy effectiveness
With the iFlash Thrombosis Panel, YHLO provides clinicians with reliable insights into coagulation and fibrinolysis, enhancing early intervention and improving patient outcomes.
Together, make a difference.”
Stay updated with Hemostasis Today.
-
Jul 10, 2026, 20:47New Machine Learning Models Improve Prediction of Thrombosis and Bleeding in Cancer – JTH
-
Jul 10, 2026, 20:39Evangelia Petsalaki: New Systems Biology Approach Identifies Biomarkers in Thrombotic APS
-
Jul 10, 2026, 20:29Wolfgang Miesbach: Celebrating Pantep Angchaisuksiri’s Transformative Leadership of the ISTH
-
Jul 10, 2026, 20:17Amy Pantaleo: How Staffing Shortages Are Changing Hemostasis Laboratories
-
Jul 10, 2026, 20:15Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
-
Jul 10, 2026, 20:15Lee G.: Can We Transform Dengue Patient Management with Better Coagulation Assessment?
-
Jul 10, 2026, 20:13Shahin Alam: Is Your Coagulant Limiting Your Water Treatment Performance?
-
Jul 10, 2026, 20:12Ali Bozorgi: Our Meta-Analysis on Oral Anticoagulation After AF Ablation Featured in EP Europace
-
Jul 10, 2026, 15:34Joy Celebre: A New Opportunity in Hemostasis Leadership